Veeva is a high-quality life sciences software compounder entering a decisive Vault CRM transition that could unlock margin expansion, AI monetization, and long-term upside despite rising Salesforce competition.
Overview
Veeva Systems is the dominant vertical cloud software provider for life sciences, serving regulated clinical, commercial, quality, and regulatory workflows where generic software struggles. Its revenue is highly recurring, with subscriptions representing 82.7% of Q1 FY2027 revenue. Built around the proprietary Vault platform, Veeva offers customers a compliant, unified system of record across drug development and commercialization. The company combines strong customer retention, deep domain specialization, and a broad life sciences footprint, but faces a pivotal migration away from Salesforce infrastructure.